99m Tc-Rituximab sentinel lymph node mapping and biopsy, the effective technique avoids axillary dissection and predicts prognosis in 533 cutaneous melanoma.

Nan LiXin ZhouHua ZhuFei WangRui GuoYan ZhangYufei SongShizhen ZhaiQing XieJiayong LiuZhongwu LiZhi Yang

Published in: Annals of nuclear medicine (2022)

Tc-rituximab could identify SLNs specifically in SLN lymphoscintigraphy and SLNB in CMM patients, and the pathology obtained from SLNB rather than from RLND better indicated the staging and long-term prognosis.

Keyphrases

sentinel lymph node
lymph node
early stage
neoadjuvant chemotherapy
end stage renal disease
diffuse large b cell lymphoma
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
ultrasound guided
high resolution
squamous cell carcinoma
locally advanced
radiation therapy